In a landmark collaboration, Novo Nordisk Philippines has officially partnered with Rose Pharmacy to expand access to patient-centered obesity care in Cebu City and across the Visayas region.
Bridging the Gap in the Visayas
The partnership aims to dismantle the persistent barriers that prevent people from seeking help: limited awareness, social stigma, and the difficulty of finding trained healthcare professionals.
By leveraging Rose Pharmacy’s extensive retail network, the initiative brings medical expertise directly into the community. Patients in Cebu can now access reliable information and a more seamless path to professional treatment.
“Obesity is a chronic, complex disease that requires sustained care and support,” says Wei Sun, General Manager of Novo Nordisk Philippines. “By partnering with Rose Pharmacy, we hope to help more Filipinos in Cebu access the right treatment and long-term care they deserve.”
The ‘Live Lighter’ Movement: A New National Perspective
This partnership is a key pillar of Novo Nordisk’s broader Live Lighter movement. The initiative is a call to action for Filipinos to stop viewing obesity as a personal failure and start recognizing it as a biological medical condition.
The urgency of this movement is backed by staggering data. The EpiCOb-PH study estimates that obesity cost the Philippine economy approximately Php 1.9 trillion in 2025—roughly 7.3% of the nation’s GDP. When overweight-related conditions are included, that figure climbs to Php 2.7 trillion.
The Role of Science: Introducing Wegovy®
Central to this new era of care is the introduction of innovative, science-based treatments. Novo Nordisk recently launched Wegovy® (semaglutide) in the Philippines.
Unlike traditional weight-loss supplements, this GLP-1 receptor agonist works with the body’s internal biology to:
Regulate appetite and hunger signals.
Manage energy intake.
Address the underlying metabolic processes that make sustained weight loss difficult through diet and exercise alone.
Dr. Christiana Vida Montefalcon, head of Clinical, Medical, and Regulatory affairs at Novo Nordisk Philippines, emphasizes that these advancements provide a "sustainable path toward better health," focusing on overall well-being rather than just the number on the scale.
A Supportive Path Forward
For Cebuanos, the message is clear: You don’t have to do this alone.
Michael So, General Manager of Rose Pharmacy, believes pharmacies are the frontline of this change. “We want to make it easier for more Cebuanos to access reliable information and the support they need to manage obesity with confidence and dignity.”
Through the combination of Rose Pharmacy’s trusted reach and Novo Nordisk’s clinical innovation, the "Live Lighter" movement is ensuring that the journey toward health is guided by science, supported by experts, and free from judgment.
Are you ready to treat obesity right? Visit your local Rose Pharmacy in Cebu to learn more about the Live Lighter movement and how to connect with healthcare professionals today.

















.jpg)

